Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CMS May Review Rx Prices In Medicare Bids; “Non-Interference” Has Limits

Executive Summary

The Medicare Part D implementing regs would allow CMS to ask drug plan sponsors to provide detailed descriptions of manufacturer-level prices and rebates in cases where bids appear "unusually" high or low

You may also be interested in...

PBMs Still Skeptical Of Part D; Is “Donut Hole” A Lifesaver?

Potential Medicare prescription drug insurance plan providers should consider the "donut hole" to be a form of reinsurance that limits their exposure to risk, the Centers for Medicare & Medicaid Services suggests

CMS Shutdown Of Drug Pricing Site In 2006 Will Create “Chaos” – Scully

Consumers will "flip out" when the Centers for Medicare & Medicaid Services shuts down the price comparison website for drug discount cards in January 2006, former Centers for Medicare & Medicaid Services administrator Tom Scully predicts

HHS Rx Price Negotiations Could Gain Bipartisan Support, Consultant Says

Congress will move to strike down the Medicare Rx law's "non-interference" provision in the next two years, former Senate Finance Committee health advisor Kathleen Means said at the Biotechnology Industry Organization's annual conference in San Francisco June 9

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts